We were founded in Brazil 17 years ago as a bootstrapped startup in a garage. Our unified end-to-end customer experience (CX) communications platform provides companies with (i) solutions focused on campaigns, sales teams, customer service and engagement, (ii) tools such as software application programming interfaces (APIs), chatbots, single customer view, journey designer, documents composer and authentication and (iii) channels […]

We are a clinical stage biopharmaceutical company applying our pioneering DARPin® product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology. Our DARPin platform, which is designed using ankyrin repeat proteins, allows us to build product candidates with multiple mechanisms of action to address complex biological problems, while potentially […]

Note: Actress Jessica Alba founded The Honest Co. in 2012. In her Founder’s Letter, she writes about her life – born into a hardworking Mexican-American family – and the hardship of suffering from severe asthma and allergies as a child. She was inspired to create this company after suffering a severe allergic reaction to laundry […]

We are a preclinical biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. We are leveraging our proprietary PREDATORTM platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional pro-inflammatory immune therapies. Our molecules, […]

(Note: Privia Health priced its upsized IPO on April 28, 2021, at $23 – the top of its upwardly revised range of $21 to $23 – on 19.5 million shares, the same number as in the prospectus, to raise $448.5 million. Privia had increased its price range to $21 to $23, up from $17 to […]

(Note: hear.com N.V. withdrew its IPO plans in an SEC filing dated March 16, 2022. The Dutch hearing aid company postponed its IPO just before noon EDT on May 13, 2021, citing the volatile U.S. stock market, just hours ahead of its scheduled IPO pricing after the market’s close.) At hear.com, we are on a […]

(Note: This IPO, filed in April 2021, was withdrawn on March 14, 2022. The proposed IPO in 2021 was part of a global offering, consisting of an international offering and a concurrent Peruvian offering. Camposol’s principal executive offices are in Lima, Peru; the company is incorporated in Cyprus. Camposol previously filed for a U.S. IPO […]

(Note: The Fortegra Group withdrew its IPO in an SEC  filing dated April 28, 2021, which was the IPO’s scheduled pricing date; the withdrawal filing was disclosed on April 29, 2021, by the SEC. Fortegra first went public in 2010. Tiptree acquired Fortegra in 2014.)  We are an established, growing and consistently profitable specialty insurer. […]

(Note: Aveanna Healthcare priced its downsized IPO at $12 – the low end of its sharply lowered range of $12 to $13 – on 38.24 million shares – the same number of shares as in the prospectus – to raise $458.88 million. Aveanna had cut its price range to $12 to $13 – down from […]

We are a software-as-a-service, or SaaS, provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China. Leveraging self-developed cloud-native architecture, AI and machine learning capabilities, patented Voice over Internet Protocol or VoIP, application technologies, no-code development platform, and in-depth industry expertise, we primarily provide holistic software solutions to help our corporate clients […]